Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents and Their Prognostic Impact
Author Information
Author(s): Bertuzzi Clara, Righi Simona, Motta Giovanna, Rossi Maura, Carella Matteo, Gabrielli Giulia, Facchini Elena, Baldassarre Maurizio, Prete Arcangelo, Zinzani Pier Luigi, Agostinelli Claudio, Sabattini Elena
Primary Institution: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Hypothesis
What are the immune checkpoint inhibitors therapeutic targets and specific T-cell subsets in adolescent patients with Classical Hodgkin’s lymphoma?
Conclusion
The study found that the microenvironment of Classical Hodgkin’s lymphoma in adolescents contains potential therapeutic targets for immune checkpoint inhibitors, with specific T-cell characteristics that relate to disease progression.
Supporting Evidence
- All patients expressed immune checkpoint molecules CTLA-4, LAG-3, and PD-1 in their microenvironment.
- A higher number of PD-1+ cells was associated with advanced disease stages.
- Lower amounts of CD8+ T-cells at diagnosis were linked to higher risks of recurrence and progression.
Takeaway
This study looked at young people with a type of cancer called Hodgkin's lymphoma and found that certain immune cells in their bodies could help doctors decide how to treat them better.
Methodology
The study analyzed formalin-fixed paraffin-embedded tissue samples from adolescent patients diagnosed with Classical Hodgkin’s lymphoma using immunohistochemistry to assess immune checkpoint molecules and T-cell markers.
Potential Biases
Potential biases may arise from the selection of patients and the retrospective nature of the study.
Limitations
The study is limited by its retrospective design and the small sample size of adolescent patients.
Participant Demographics
Participants were adolescents aged 12 to 18 years, with a majority being female (55.6%).
Statistical Information
P-Value
0.032
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website